Neurocrine Bioscience buy Royal Bank of Canada
Start price
12.02.26
/
50%
€105.60
Target price
12.02.27
€149.00
Performance (%)
-1.80%
Price
12.02.26
€103.70
Summary
This prediction is currently active. With a performance of -1.80%, the BUY prediction for Neurocrine Bioscience by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 12.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -1.80% |
| iShares Core DAX® | 1.301% |
| iShares Nasdaq 100 | 0.612% |
| iShares Nikkei 225® | 8.772% |
| iShares S&P 500 | 0.254% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Royal Bank Of Canada from $180.00 to $177.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€137.35
08.12.25
08.12.25
€154.48
08.12.26
08.12.26
-24.50%
12.02.26
12.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€137.36
29.10.26
29.10.26
-12.01%
12.02.26
12.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.05
05.09.25
05.09.25
€127.74
05.09.26
05.09.26
-15.73%
12.02.26
12.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€125.97
31.07.26
31.07.26
-7.78%
12.02.26
12.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.85
02.06.25
02.06.25
€127.53
02.06.26
02.06.26
-4.73%
12.02.26
12.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
-2.08%
12.02.26
12.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€83.38
14.04.25
14.04.25
€120.31
14.04.26
14.04.26
24.37%
12.02.26
12.02.26

